Results 201 to 210 of about 77,535 (306)

Preemptive Rituximab for Epstein–Barr Virus Reactivation after Hematopoietic Cell Transplantation: Necessary for All?

Transplant Infectious Disease, EarlyView.
A sudden increase in EBV DNAemia appears to be a better predictor of PTLD and EBV end‐organ disease than persistent and stable levels of EBV DNAemia. Most HCT recipients with EBV DNAemia did not require rituximab, and immunosuppression reduction was sufficient to control most episodes of EBV reactivation.
Anna Beatriz Coelho de Souza, Anderson João Simione, Ana Cláudia Ferrari dos Santos, Iago Colturato, Fernanda Rodrigues Barbieri, Juliana Ribeiro do Prado Moreno, Lilian Perílio Zanetti, Leila Cibele Serra de Oliveira, Erika Rodrigues Pontes Delattre, Juliana Silva Santos, Mair Pedro de Souza, Vergílio A. R. Colturato, Clarisse M. Machado   +12 more
wiley   +1 more source

Relapsed Classical Hodgkin Lymphoma in Pregnancy in Two Patients Managed With a Multidisciplinary Approach. [PDF]

Case Rep Oncol Med
Zaidi M, Naqvi A, Rios J, Khosla M, Hassanain H, Giese N, Burns EA, Mai H, Yuen C, Shah S, Ganguly S, Pingali SR.   +11 more
europepmc   +1 more source

HHV‐8/KSHV in Solid Organ Transplantation: Current Gaps of Knowledge and Future Directions

Transplant Infectious Disease, EarlyView.
Risk mitigation strategies, including donors/recipients screening, DNAemia monitoring in recipients at risk, CNI‐to‐mTOR inhibitors switch, antivirals, and rituximab for KICS, may mitigate the impact of HHV‐8/KSHV infection in SOT. This review provides an update on KICS, identifies research gaps, and summarizes advances in screening and management ...
Alessandra Mularoni, Andrea Cona, Malgorzata Mikulska, Francesca Pecoraro, Carlotta Piazza, Elda De Vita, Giada Pietrosi, Matteo Bulati, Tiziana Lazzarotto, Mario Luppi   +9 more
wiley   +1 more source

A Rare Case of Bullous Pemphigoid Triggered by Overlapping Immune Dysregulation From HIV and Hodgkin Lymphoma: A Case Report. [PDF]

Cureus
Palacio I, Arraut K, Portalatin K, Estil-Las AA, Grace M.   +4 more
europepmc   +1 more source

Pediatric autologous peripheral blood stem cell collection without heparin using a highly concentrated sodium citrate anticoagulant: A retrospective comparison with standard ACD‐A

Transfusion, EarlyView.
Abstract Background Heparin combined with sodium citrate has been used in leukocytapheresis for pediatric patients. Since 2022, we have performed leukocytapheresis using a highly concentrated sodium citrate solution (HSC, 5.32%) instead of acid citrate dextrose solution A (ACD‐A).
Keiko Fujii, Wataru Kitamura, Kana Washio, Kazuhiro Ikeuchi, Joji Shimono, Hiroyuki Murakami, Fumio Otsuka, Yoshinobu Maeda, Nobuharu Fujii   +8 more
wiley   +1 more source

Proteinuria With Functionally Normal Kidneys: A Hidden Clue to the Diagnosis of Diffuse Large B-cell Lymphoma (DLBCL) With Secondary Glomerular Infiltration. [PDF]

Cureus
Babu Satheendranath B, John D, Kumar V, Raza A, Verma R.   +4 more
europepmc   +1 more source

Hodgkin's disease. I. [PDF]

BMJ, 1967
openaire   +4 more sources

Phase 1 Dose Escalation of Single‐Agent Mechlorethamine in Dogs With Lymphoma

Veterinary and Comparative Oncology, EarlyView.
ABSTRACT Mechlorethamine is commonly prescribed to dogs at 3 mg/m2. The minimal toxicity observed indicates that higher doses of mechlorethamine are likely tolerable. The primary objective of this study was to determine the maximally tolerated dose (MTD) of mechlorethamine in dogs with lymphoma.
Laura E. Chadsey, Paul R. Hess, Joanne L. Intile   +2 more
wiley   +1 more source

Cholestatic Jaundice as the Initial Manifestation of Classical Hodgkin Lymphoma: A Diagnostic Challenge. [PDF]

Cureus
Grossmann I, Vavrukh P, Balderacchi J, Ahsan S, Sanekommu H.   +4 more
europepmc   +1 more source

IgG4-related disease simulating Hodgkin lymphoma in a child

, 2015
D. Eric Ewing, Richard Hammer
openalex   +1 more source